1.
|
12 p, 2.6 MB |
Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
/
Mena, Marisa (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III) ;
Wang, Xin (Institut d'Investigació Biomèdica de Bellvitge) ;
Tous, Sara (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III) ;
Quirós, Beatriz (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III) ;
Clavero, Omar (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III) ;
Alejo, Maria (Hospital General de l'Hopitalet. Pathology Department) ;
Morey, Francisca (Institut d'Investigació Biomèdica de Bellvitge) ;
Taberna, Miren (Institut d'Investigació Biomèdica de Bellvitge) ;
León i Vintró, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Lloveras Rubio, Belén (Hospital del Mar. Pathology Department) ;
Alos, Llucìa (Hospital Clínic i Provincial de Barcelona) ;
Mehanna, Hisham (Institute of Head and Neck Studies and Education. University of Birmingham) ;
Quint, Wim (DDL Diagnostic Laboratory) ;
Pawlita, Michael (Division of Molecular Diagnostics of Oncogenic Infections. Research Program Infection. Inflammation and Cancer. German Cancer Research Center (DKFZ)) ;
Tommasino, Massimo (Infections and Cancer Biology Group. International Agency for Research on Cancer (IARC)) ;
Pavón, Miguel Angel (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III) ;
Muñoz, Nubia (National Cancer Institute) ;
De Sanjose, Silvia (ISGlobal) ;
Bosch, Francesc Xavier (Universitat Oberta de Catalunya) ;
Alemany, Laia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública. Instituto de Salud Carlos III)
Background: Tests or test algorithms for diagnosing HPV-driven oral cavity and laryngeal head and neck carcinomas (HNC) have not been yet validated, and the differences among oral cavity and laryngeal sites have not been comprehensively evaluated. [...]
2022 - 10.3390/cancers14153787
Cancers, Vol. 14 Núm. 15 (august 2022) , p. 3787
|
|
2.
|
17 p, 277.3 KB |
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer : results from the EPIC Cohort
/
Roura, Esther (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Travier, Noémie (Institut Català d'Oncologia) ;
Waterboer, Tim (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
De Sanjose, Silvia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Bosch José, Francesc Xavier 1947- (Institut Català d'Oncologia) ;
Pawlita, Michael (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Pala, Valeria (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) ;
Weiderpass, Elisabete (Folkhälsan Research Center, Helsinki, Finland) ;
Margall, Núria (Institut d'Investigació Biomèdica Sant Pau) ;
Dillner, Joakim (Karolinska Institutet (Estocolm, Suècia)) ;
Gram, Inger T. (UiT The Arctic University of Norway, Tromsø, Norway) ;
Tjønneland, Anne (Danish Cancer Society Research Center, Copenhagen, Denmark) ;
Munk, Christian (Danish Cancer Society Research Center, Copenhagen, Denmark) ;
Palli, Domenico (Cancer Research and Prevention Institute-ISPO, Florence, Italy) ;
Khaw, Kay-Tee (University of Cambridge) ;
Overvad, Kim (Aarhus University, Aarhus, Denmark) ;
Clavel-Chapelon, Françoise (Institut Gustave Roussy (Villejuif, França)) ;
Mesrine, Sylvie (Institut Gustave Roussy (Villejuif, França)) ;
Fournier, Agnès (Institut Gustave Roussy (Villejuif, França)) ;
Fortner, Renée T. (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Ose, Jennifer (German Cancer Research Center (DKFZ), Heidelberg, Germany) ;
Steffen, Annika (German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany) ;
Trichopoulou, Antonia (Hellenic Health Foundation, Athens, Greece) ;
Lagiou, Pagona (Harvard School of Public Health, Boston, United States of America) ;
Orfanos, Philippos (University of Athens Medical School, Athens, Greece) ;
Masala, Giovanna (Cancer Research and Prevention Institute-ISPO, Florence, Italy) ;
Tumino, Rosario ("Civic-M.P. Arezzo" Hospital, Ragusa, Italy) ;
Sacerdote, Carlotta (Centre for Cancer Epidemiology and Prevention (CPO Piemonte), Turin, Italy) ;
Polidoro, Silvia (Human Genetics Foundation (HuGeF), Turin, Italy) ;
Mattiello, Amalia (Federico II University, Naples, Italy) ;
Lund, Eiliv (UiT The Arctic University of Norway, Tromsø, Norway) ;
Peeters, Petra H. (University Medical Center Utrecht, Utrecht, The Netherlands) ;
Bueno-de-Mesquita, H. Bas (University of Malaya, Kuala Lumpur, Malaysia) ;
Quirós, J. Ramón (Dirección de Salud Pública de Asturias) ;
Sánchez, María-José (Instituto de Investigación Sanitaria de Granada) ;
Navarro Sánchez, Carmen (Universidad de Murcia) ;
Barricarte, Aurelio (Instituto de Investigación Sanitaria de Navarra) ;
Larrañaga, Nerea (Biodonostia Osasun Ikerketako Institutura (País Basc)) ;
Ekström, Johanna (Lund University, Medicon Village, Lund, Sweden) ;
Lindquist, David (Department of Radiation Sciences, Umeå University, Umeå, Sweden) ;
Idahl, Annika (Umeå University, Umeå, Sweden) ;
Travis, Ruth C. (University of Oxford, Oxford, United Kingdom) ;
Merritt, Melissa A. (Imperial College London, London, United Kingdom) ;
Gunter, Marc J. (Imperial College London, London, United Kingdom) ;
Rinaldi, Sabina (International Agency for Research on Cancer, Lyon, France) ;
Tommasino, Massimo (International Agency for Research on Cancer, Lyon, France) ;
Franceschi, Silvia (International Agency for Research on Cancer, Lyon, France) ;
Riboli, Elio (Imperial College London, London, United Kingdom) ;
Castellsagué, Xavier (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Universitat Autònoma de Barcelona
In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). [...]
2016 - 10.1371/journal.pone.0147029
PloS one, Vol. 11 (january 2016)
|
|
3.
|
11 p, 2.9 MB |
Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
/
De Sanjose, Silvia (PATH, Scale-Up Project Director, Sexual and Reproductive Health Global Program) ;
Serrano, Beatriz (Centro de Investigación Biomédica en Red de Cáncer) ;
Tous, Sara (Centro de Investigación Biomédica en Red de Cáncer) ;
Alejo, Maria (Hospital General de l'Hospitalet) ;
Lloveras, Belén (Hospital del Mar (Barcelona, Catalunya)) ;
Quirós, Beatriz (Centro de Investigación Biomédica en Red de Cáncer) ;
Clavero, Omar (Centro de Investigación Biomédica en Red de Cáncer) ;
Vidal, August (Hospital Universitari de Bellvitge) ;
Ferrandiz-Pulido, Carla (Hospital Universitari Vall d'Hebron) ;
Pavón, Miquel Ángel (Centro de Investigación Biomédica en Red de Cáncer) ;
Holzinger, Dana (German Cancer Research Center (DKFZ)) ;
Halec, Gordana (David Geffen School of Medicine at UCLA.Obstetrics and Gynecology Department) ;
Tommasino, Massimo (International Agency for Research on Cancer Infections) ;
Quint, Wim (DDL Diagnostic Laboratory) ;
Pawlita, Michael (German Cancer Research Center (DKFZ)) ;
Muñoz, Nubia (National Cancer Institute of Colombia) ;
Bosch José, Francesc Xavier 1947- (Centro de Investigación Biomédica en Red de Cáncer) ;
Alemany, Laia (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Universitat Autònoma de Barcelona
Many countries, mainly high- and upper-middle income, have implemented human papillomavirus (HPV) vaccination programs, with 47 million women receiving the full course of vaccine (three doses) in 2014. [...]
2019 - 10.1093/jncics/pky045
JNCI Cancer Spectrum, Vol. 2 (january 2019)
|
|